All In Biotech

Drug Trial Radar · NCT04212000

Bioavailability of Levoketoconazole and Ketoconazole Tablets

A Phase 1 Randomized, Open-Label, Two-Period,Two-Sequence Crossover Study to Evaluate the Relative Oral Bioavailability of Levoketoconazole and Ketoconazole Tablets in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: Jan 31, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

34

Actual

Start

Dec 16, 2019

Primary completion

Jan 18, 2020

Study completion Jan 23, 2020

Sponsor

Lead sponsor
Cortendo ABIndustry
Sponsor type
Industry
First posted
Dec 26, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a phase 1, randomized, open-label, single-dose, two-period, two-sequence crossover study in healthy male and female subjects to evaluate the relative oral bioavailability of levoketoconazole tablets (the test drug) and ketoconazole tablets (the reference drug product).

Conditions

  • Healthy

Interventions

  • LevoketoconazoleDrug

    Levoketoconazole tablet

  • KetoconazoleDrug

    Ketoconazole tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ratio of geometric least squares means for AUClast of plasma levoketoconazole (2S,4R-ketoconazole)Time frame: 24 hours
  2. Ratio of geometric least squares means for AUCinf of plasma levoketoconazole (2S,4R-ketoconazole)Time frame: 24 hours
  3. Ratio of geometric least squares means for Cmax of plasma levoketoconazole (2S,4R-ketoconazole)Time frame: 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Pharmaceutical Research Associates, Inc.

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.